David Liang
Overview
Explore the profile of David Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pazzagli L, Liang D, Andersen M, Linder M, Khan A, Sessa M
Sci Rep
. 2022 Apr;
12(1):6245.
PMID: 35428827
The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is...
12.
Liang D, Sessa M
Expert Opin Drug Saf
. 2022 Mar;
21(9):1205-1210.
PMID: 35236231
Background: We aimed at evaluating adverse drug reactions during the post-marketing phase with erenumab as the suspected/interacting drug in Eudravigilance, with the final goal of investigating the consistency of the...
13.
Liang D, Gardella E, Kragholm K, Polcwiartek C, Sessa M
J Card Fail
. 2021 Aug;
28(4):630-638.
PMID: 34438055
Objective: To compare the hazard for all-cause mortality and mortality due to heart failure (HF) between valproate (VPA) and levetiracetam (LEV)/lamotrigine (LTG) users in patients aged ≥ 65 with comorbidities...
14.
Yuan N, Jain I, Rattehalli N, He B, Pollick C, Liang D, et al.
JACC Cardiovasc Imaging
. 2021 Jul;
14(11):2260-2262.
PMID: 34274282
No abstract available.
15.
Liang D, Song M, Niu Z, Zhang P, Rafailovich M, Deng Y
MRS Adv
. 2021 Feb;
6(13):362-367.
PMID: 33619443
Abstract: Molecular dynamics (MD) simulations are a widely used technique in modeling complex nanoscale interactions of atoms and molecules. These simulations can provide detailed insight into how molecules behave under...
16.
Sessa M, Liang D, Khan A, Kulahci M, Andersen M
Front Pharmacol
. 2021 Feb;
11:568659.
PMID: 33519433
To summarize the evidence on the performance of artificial intelligence vs. traditional pharmacoepidemiological techniques. Ovid MEDLINE (01/1950 to 05/2019) was searched to identify observational studies, meta-analyses, and clinical trials using...
17.
Pellesi L, De Icco R, Alawie H, Andersen M, Liang D, Amirguliyev S, et al.
Expert Opin Drug Saf
. 2020 Dec;
20(4):467-474.
PMID: 33337920
: Erenumab has recently been approved as a pharmacological treatment for the prevention of migraine. However, the incidence estimates of adverse drug reactions (ADRs) were not consistent among studies. Consequently,...
18.
Sessa M, Khan A, Liang D, Andersen M, Kulahci M
Front Pharmacol
. 2020 Aug;
11:1028.
PMID: 32765261
Aim: To perform a systematic review on the application of artificial intelligence (AI) based knowledge discovery techniques in pharmacoepidemiology. Study Eligibility Criteria: Clinical trials, meta-analyses, narrative/systematic review, and observational studies...
19.
McBroome J, Liang D, Corbett-Detig R
Genome Biol Evol
. 2020 May;
12(8):1378-1391.
PMID: 32437518
Chromosomal inversions are among the primary drivers of genome structure evolution in a wide range of natural populations. Although there is an impressive array of theory and empirical analyses that...
20.
Meduri C, Reardon M, Lim D, Howard E, Dunnington G, Lee D, et al.
JACC Cardiovasc Interv
. 2019 Oct;
12(23):2402-2412.
PMID: 31629753
Objectives: This study proposes a physiologic assessment of left ventricular outflow tract obstruction (LVOTO) that accommodates changes in systolic flow and accounts for the dynamic neo-left ventricular outflow tract (LVOT)....